Bayer

Bayer’s Two Timelines: A $2.2 Billion Ohio Bet and a Quarter Still Unreported

angelina -

Bayer’s Brussels Setback Overshadows Spanish Green Win and Pharma Pipeline Push

Brett Shapiro -

Bayer Balances Fresh Pipeline Wins Against a Missouri Courtroom Test

angelina -

Bayer’s Twin Catalysts Converge: A $7.25 Billion Legal Milestone and a Five-Year Agricultural Gamble

angelina -

Bayer’s September Court Date Looms Large as UBS Reaffirms Its Bullish Bet

Bayer’s Two-Speed Recovery: Operating Gains Mask a Thinner Bottom Line as Pharma Pipeline Takes Center Stage

angelina -

Bayer’s Oncology Pipeline Gains Traction in Japan, Yet the Glyphosate Clock Keeps Ticking

Brett Shapiro -

Bayer’s Two-Front Story: A Cardiology Data Drop Meets a Legal Clock That Keeps Ticking

kashif hafeez -

Bayer’s Legal Calendar Slips as Supreme Court Ruling Reshapes the Glyphosat Settlement Calculus

Brett Shapiro -

Bayer’s Two-Front Legal Strategy: From Defendant to Plaintiff While Awaiting a Landmark Ruling

kashif hafeez -

Bayer Stock’s Legal Tailwind Meets a Five-Day Slide Ahead of Earnings

Bayer’s $5 Billion Bond Sale Sends Mixed Signals as Legal Wins and Trade Tensions Collide

angelina -

Supreme Court Victory Offers Limited Shelter as Bayer Faces Glyphosate Price Squeeze and Settlement Delays

Brett Shapiro -

Bayer Balances a Two-Decade Bet on Wheat With a Near-Term Overhaul From Apollo and the Courts

angelina -

Bayer Secures €3 Billion Lifeline From Apollo While Pushing to Dismiss Thousands of Roundup Cases

Brett Shapiro -
123Page 1 of 3